Hepatitis C Genotype 1
5 clinical trials · Condition
◉ Watch Hepatitis C Genotype 1
| Record | Firm | Date |
|---|---|---|
| A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection (NCT02716428) | Trek Therapeutics, PBC | 2016-05-01 |
| Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus (NCT01471574) | Bristol-Myers Squibb | 2011-12-01 |
| ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients (NCT01464827) | AbbVie (prior sponsor, Abbott) | 2011-10-01 |
| A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV) (NCT01221298) | AbbVie (prior sponsor, Abbott) | 2010-10-01 |
| A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 (NCT01074008) | AbbVie (prior sponsor, Abbott) | 2010-03-01 |
Track Hepatitis C Genotype 1 automatically
Every clearance here is in the API, with alerts when new ones post.